Nauticus Robotics Announces Results for the Second Quarter of 2025

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

YUTREPIA™ surpasses 900 unique patient prescriptions and 550 patient starts within 11 weeks after approval to treat PAH and PH-ILDPositive interim data from ASCENT trial reinforces YUTREPIA’s tolerability and efficacy profile in PH-ILD with median improvement in six-minute walk distance…

Nauticus Robotics Announces Results for the Second Quarter of 2025

Revenue Momentum Endures; Market Diversification Continues

Xenon Reports Second Quarter 2025 Financial Results & Business Update

– Phase 3 azetukalner X-TOLE2 FOS study patient recruitment complete, with topline data anticipated in early 2026

Humacyte Announces Second Quarter 2025 Financial Results and Provides Business Update

Total revenues of $301,000 for quarter, and $818,000 for first six months of 2025, from sales and collaborative research agreement - - 82 civilian...

AST SpaceMobile Provides Business Update and Second Quarter 2025 Results

Green Stock News for the New Green Economy.